Consequently, taking albuterol can lower your potassium levels. This may make your muscles weak or cause muscle spasms, and it can also cause an abnormal heart rhythm. Other symptoms of hypokalemia include fatigue, constipation and the breakdown of muscle fibers. If you are concerned that your albuterol treatment is reducing your potassium levels, talk to your doctor.
Low potassium can be diagnosed from blood tests. If your potassium levels are only mildly low, your doctor may prescribe oral potassium supplements. More serious cases of hypokalemia need to be treated with intravenous potassium supplements. Do not stop taking your medication without talking to your doctor first. Nutrition Nutrition Basics Vitamins and Supplements. Adam Cloe. Patients: Ten patients with moderate to severe exacerbation of asthma. Interventions: Each patient received nebulized albuterol 2.
Measurements and main results: Serum potassium, heart rate and rhythm, blood pressure, and pulmonary function were measured before treatment and every 15 minutes for 2 hours after treatment. No statistically significant changes in blood pressure, heart rate, or corrected QT intervals occurred. A nebulized solution of 2. Dosing of 1. For the powdered and aerosol metered-dose inhaler, the advice to use one or two puffs of 90 mcg every four to six hours depending on the patient, but it is advised not to exceed 12 puffs within 24 hours.
For tablet and syrup formulations, 2 to 4 mg every 6 to 8 hours is recommended with the advisory not to exceed 32 mg in one day. For the treatment of acute or severe bronchospasm, it is advisable to use a nebulizer solution with a concentration of 2. Treatment can be maintained with continuous nebulizer treatments every 10 to 15 minutes.
If treating with a metered-dose inhaler, 4 to 8 puffs of 90 mcg every 20 minutes for up to 4 hours is a standard practice followed by 4 to 8 puffs every 1 to 4 hours as needed. For exercise-induced bronchospasm, the recommendation is to treat with aerosol or powder metered-dose inhaler before exercise.
Two puffs of 90 mcg for a total of mcg taken 15 to 20 minutes prior to exercise may help prevent symptoms. For the treatment of pediatric patients, age becomes a significant factor in the course of treatment.
For children under two years old, nebulizer solution with dosing by weight of 0. For children two years old and older, a nebulizer solution dosing of the 2. The use of aerosol metered-dose inhalers in the pediatric population under the age of 4 years old has not had research conducted. The dosing recommendation for four years and older is 90 to mcg 1 to 2 puffs every 4 to 6 hours.
The use of powder metered-dose inhalers in the pediatric population under the age of 4 years old has not been studied. Dosing recommendation for four years and older to take mcg 2 puffs every 4 to 6 hours not to exceed 12 puffs within 24 hours. The dosing of albuterol tablets in pediatric patients under six years old is 0. For those ages 6 to 12, 2 mg every 6 to 8 hours is the recommended dosage with a daily maximum of 24 mg per day.
For pediatric patients over the age of 12, 2 to 4 mg given every 6 to 8 hours with a daily maximum of 32 mg. Extended-release albuterol tablets are not recommended for those under the age of 6. For pediatric patients between 6 and 12 years of age, the recommendation is for a dose of 4 mg every 12 hours is given, not to exceed 24 mg in 24 hours.
For pediatric patients over the age of 12, 8 mg taken every 12 hours is the recommended dose. The syrup formulation has not been studied in children under the age of 2. For patients between the ages of 2 and 6, the dose is 0. This dosing can increase if needed, to 0. For those 6 to 14 years of age, 2 mg taken every 6 to 8 hours should suffice.
The primary adverse effects of albuterol therapy are tremors and nervousness, mostly seen in children who are 2 to 6 years of age, though can be seen at any age. Tremors are the result of activation of the beta-2 receptors found on the motor nerve terminals which increases intracellular cAMP. These side effects occur in approximately one in every five patients. Other side effects include insomnia and nausea, which occur in approximately 1 in every ten patients.
0コメント